Sushen Medicamentos Private Limited, a active private limited company, was established on 17 October 2001 in Ahmedabad, Gujarat, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U24231GJ2001PTC040113. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.88 Cr.
It upholds a compliant status. Employing 39 professional, Its leadership includes Aman Kulabkar (Director), Kaushik Kantilal Shah (Managing Director). Past directors included Aman Kulabkar, Deepak Madhukar Kulabkar, Kaushik Kantilal Shah. It holds ₹15.11 Cr open charges and ₹1.99 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 105 Aatish Annexe Off C Groad Gulbai Tekra, Ahmedabad, Gujarat, 380006.
U24231GJ2001PTC040113
040113
17 October 2001
₹3.00 Cr
₹2.88 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Sushen Medicamentos Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aman Kulabkar | Director | 01 May 2021 | Current |
| Kaushik Kantilal Shah | Managing Director | 01 Jul 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Managing Director | 22 Apr 2021 | Past |
| Pramod Abcsdd | Director | 15 Jul 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sushen Medicamentos Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.77% increase. The company also saw a substantial improvement in profitability, with a 176.33% increase in profit. The company's net worth dipped by a decrease of 6.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sushen Medicamentos had a public holding of 2.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹151,100,000.00
₹19,917,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2012 | Axis Bank Limited | ₹15.11 Cr | Open |
| 23 Mar 2018 | Axis Bank Limited | ₹2.47 M | Satisfied |
| 27 Apr 2016 | Others | ₹1.55 M | Satisfied |
| 23 Sep 2011 | Kotak Mahindra Bank Limited | ₹1.59 Cr | Satisfied |
Explore comprehensive loan charge details -
Sushen Medicamentos has a workforce of 39 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sushen Medicamentos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sushen Medicamentos's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited of Rs. 15.11 Cr registered on 29 Dec 2012 with Charge ID 10400319 was modified on 30 Sep 2025. was recorded as a recent event.
Progress on Sushen Medicamentos Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Sushen Medicamentos Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
The activity A charge registered on 23 Mar 2018 via Charge ID 100169863 with Axis Bank Limited was fully satisfied on 12 Mar 2022. was completed.
The activity A charge registered on 27 Apr 2016 via Charge ID 100024038 with Others was fully satisfied on 18 Oct 2021. was completed.
Progress on Aman Kulabkar was appointed as a Director was appointed as a Director on 01 May 2021 & has been associated with this company since 4 years 7 months . was documented.
The CIN of Sushen Medicamentos Private Limited is U24231GJ2001PTC040113.
Sushen Medicamentos Private Limited is headquartered at 105 Aatish Annexe Off C Groad Gulbai Tekra, Ahmedabad, Gujarat, 380006.
Sushen Medicamentos Private Limited was incorporated on 17 October 2001.
The current directors of Sushen Medicamentos Private Limited are
The primary industry of Sushen Medicamentos Private Limited is Manufacturing.
Sushen Medicamentos Private Limited is unlisted.
The authorized capital of Sushen Medicamentos Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.88 Cr.
The compliance status of Sushen Medicamentos Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX